Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Topical Finasteride in the Treatment of Idiopathic Hirsutism

This study has been completed.
Sponsor:
Collaborator:
Firuzgar hospital affiliated to Iran University of Medical Sciences
Information provided by:
Iran University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00564252
First received: November 26, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
  Purpose

the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism


Condition Intervention
Idiopathic Hirsutism
Drug: topical finasteride

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism

Resource links provided by NLM:


Further study details as provided by Iran University of Medical Sciences:

Primary Outcome Measures:
  • the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication [ Time Frame: 6 months ]

Enrollment: 56
Study Start Date: February 2006
Study Completion Date: October 2006
Intervention Details:
    Drug: topical finasteride
    0.2%topical(cream)finasteride twice a day for six months
  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
  • Normal serum prolactin

Exclusion Criteria:

  • Pregnancy
  • Simultaneous use of other drugs for the treatment of hirsutism
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00564252

Sponsors and Collaborators
Iran University of Medical Sciences
Firuzgar hospital affiliated to Iran University of Medical Sciences
Investigators
Study Director: iraj heydari, professor assistant endocrine and metabolism centre of Iran University of Medical Sciences
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00564252     History of Changes
Other Study ID Numbers: 84-5-6886, IUMS127
Study First Received: November 26, 2007
Last Updated: November 26, 2007
Health Authority: Iran: Ethics Committee

Additional relevant MeSH terms:
Hirsutism
Hypertrichosis
Hair Diseases
Signs and Symptoms
Skin Diseases
Virilism
Finasteride
5-alpha Reductase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Urological Agents

ClinicalTrials.gov processed this record on November 20, 2014